BioSpace News Archive

Business

Besties Regeneron and Sanofi Add Another $1B to PD-1 I/O Deal

The two companies struck the deal in 2015.

January 8, 2018
·
14 min read
Business

CytoSorbents Pre-Announces Preliminary Fourth Quarter and Full Year 2017 Results and Issues Stockholder Letter

CytoSorbents pre-announces preliminary unaudited fourth quarter 2017 and full year 2017 results ahead of filing its Form 10-K, and issues a stockholder letter from Dr. Phillip Chan, Chief Executive Officer of CytoSorbents.

January 8, 2018
·
9 min read
Drug Development

Ra Pharmaceuticals Initiates Dosing in Phase Ib Pharmacokinetic Study Evaluating RA101495 SC in Patients with Renal Impairment

This trial is designed to characterize the pharmacokinetics (PK) of RA101495 SC in these patients, thereby enabling the evaluation of RA101495 SC in complement-mediated renal diseases, such as atypical hemolytic uremic disorder (aHUS) and lupus nephritis (LN).

January 8, 2018
·
5 min read
Business

IDEXX to Introduce Applied BioCode’s Innovative Multiplex Technology Across Global Reference Laboratory Network

IDEXX and Applied BioCode today announced that they have entered into an exclusive global agreement to bring Applied BioCode’s digital multiplex platform to IDEXX Reference Laboratories customers.

January 8, 2018
·
4 min read
Business

Invitae More Than Doubles Annual Volume, Exceeds Full-Year 2017 Guidance, and Projects Momentum to Continue in 2018

For 2018, the company announced it anticipates accessioning at least 250,000 samples and generating at least $120M in revenue for the combined organization.

January 8, 2018
·
4 min read
Biotech Beach

SoCal’s Neural Analytics Banks $15M

Neural Analytics announced that it has raised $15 million in Series B financing led by Alpha Edison.

January 8, 2018
·
3 min read
Drug Development

AbbVie’s Upadacitinib Granted Breakthrough Therapy Designation From the FDA for Atopic Dermatitis

AbbVie today announced the FDA granted Breakthrough Therapy Designation for the investigational, once-daily oral JAK1-selective inhibitor upadacitinib in adult patients with moderate to severe atopic dermatitis who are candidates for systemic therapy.

January 8, 2018
·
7 min read
Deals

Henry Schein Acquires Majority Interest in ABASE, a Distributor of Veterinary Health Care Products in Sao Paulo, Brazil

Henry Schein announced today that it has acquired a 60 percent ownership investment in ABASE.

January 8, 2018
·
6 min read
Business

PTC Therapeutics Provides Corporate Update and Outlines 2018 Strategic Priorities

PTC Therapeutics today provided a corporate update, which will be detailed as part of the company’s presentation at the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10th at 2:30 pm PT.

January 8, 2018
·
11 min read
Biotech Bay

Unchained Labs Gives Lunatic a Boost, Nails High-End Biologic Quant!

Lunatic’s new IgG Quant app hits the upper analysis range needed to measure these protein drugs, and does it with only 2 µL of sample straight up - no dilution needed.

January 8, 2018
·
1 min read